Hemostasis and coagulation

Several investigators (9, 21, 22) have found that foreign surfaces, when exposed to blood, adsorb plasma proteins. Since platelet adhesion to the surface is the first observable event occurring in clotting on foreign surfaces, and since platelets are known to participate in hemostasis and coagulation, the indication is that platelet adhesion onto the plasma protein-coated surface plays a major role in the in vivo initiation of thrombus formation on foreign surfaces. 

Upon activation, platelets release several factors, which are normally involved in hemostasis and coagulation, and are also implicated in TCIPA (Honn et al., 1992b).These factors can be recovered from activated platelets and tested on tumor cells. 

The clinical applications of HES have been reviewed by Lutz (1975) and Thompson (1978). For particular pharmacologic and biologic effects of HES see the following literature hemostasis and coagulation (Alexander 1978), intravascular persistence in humans (Thompson et al. 1970 Boon et al. 1976), and storage in animals (Lindblad and Falk 1976). 

We shall first describe the coagulation pathway leading to the formation of fibrin. Then we shall briefly describe some aspects of the involvement of platelets and blood vessel walls in the overall process. This separation of clotting factors and platelets is artificial, since both play intimate and often mutually interdependent roles in hemostasis and thrombosis, but it facifitates description of the overall processes involved. 

Hemostasis and thrombosis are complex processes involving coagulation factors, platelets, and blood vessels. 

The chapter on plasma proteins, immunoglobulins, and blood coagulation in the previous edition has been split into two new chapters on plasma proteins and immunoglobuhns and on hemostasis and thrombosis. 

Describe the processes of hemostasis and thrombosis, including the role of the vascular endothelium, platelets, coagulation cascade, and thrombolytic proteins. 

Self-protection. To prevent blood loss when a vessel is injured, the blood has systems for stanching blood flow and coagulating the blood (hemostasis see p. 290). The dissolution of blood clots (fibrinolysis) is also managed by the blood itself (see p. 292). 

Little intravascular coagulation of blood occurs in normal physiological conditions. Hemostasis involves the interplay of three procoagulant phases vascular, platelet, and coagulation) that promote blood clotting to prevent blood loss (Fig. 22.1). The fibrinolytic system prevents propagation of clotting beyond the site of vascular injury and is involved in clot dissolution, or lysis (Fig. 22.2). 

Connolly AJ, Ishihara H, Kahn ML et al. (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature 381 516-519 Cui J, O Shea KS, Purkayastha A et al. (1996) Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 384 66-68 Denis C, Methia N, Frenette PS et al. (1998) A mouse model of severe von Willebrand disease defects in hemostasis and thrombosis. Proc Nad Acad Sci USA 95 9524-9529 Dewerchin M, Liang Z, Moons L et al. (2000) Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost 83 185-190... 

Walsh PN. Platelet-coagulant protein interactions. In Colman RW, Hirdi J, Marder VI, Salzman EW eds Hemostasis and Thrombosis Basic principles and clinical practice. Philadelphia J.B. Li] incott 1994 629-51. 

As with other beta-lactam antibiotics, cephalosporins can cause impaired hemostasis and bleeding by altering coagulation and platelet fnnction. 

C. M. Jackson Hemostasis and blood coagulation. Encyclopedia of Human Biology, R. Dulbecco, (Ed), Academic Press, Inc., San Diego, Vol. 2, Second Edition 23 (1997). 

The metabolic countermeasures are characterized by the regulatory role of ascorbate for metabolic systems determining the clinical risk profile for CVD. The common aim of these metabolic regulations is to decrease the vascular permeability in ascorbate deficiency. Low ascorbate concentrations therefore induce vasoconstriction and hemostasis and affect vascular wall metabolism in favor of atherosclerogenesis. Towards this end ascorbate interacts with lipoproteins, coagulation factors, prostaglandins, nitric oxide, and second messenger systems such as cyclic monophosphates (for review see 1, 3-5). It... 

J. B. Lefkowitz, Coagulation Pathway and Physiology [Online]. Available http //www.cap.org/apps/docs/cap press/hemostasis testing/coagulation pathway.pdf. 

Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vase Biol 2007 27(8) 1687-93. 

GoUub, S., Schachter, D. C., and Ulin, A. W., Hemostasis blood coagulation and isobutylcyanoacrylate tissue adhesive, Surg. Gynecol. Obstet., 130, 2, 1970. 

---